New study tracks hidden struggles of rare head and neck cancer survivors
NCT ID NCT05733091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 300 people treated for sinonasal, nasopharyngeal, or skull base tumors to track their symptoms and functional changes over time. Participants will complete symptom questionnaires and undergo standard tests like hearing, eye, and speech exams. The goal is to learn how treatment affects daily life, so doctors can better support future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and manage long-term symptoms and side effects for people treated for these rare head and neck tumors.
- What could go wrong
- This is an observational study, not testing a new treatment. It will not directly improve outcomes for participants, and results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mapping the hidden toll of brain radiation on young minds
- AI analyzes 10,000 patient records to predict head and neck cancer recurrence
- New MRI technique could help surgeons avoid nerve damage
- New drug E7090 tested in patients with advanced solid tumors
- New MRI tracks Cancer's energy use to spot tumors